Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Truist Financial Corp

Truist Financial Corp decreased its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 25.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 42,024 shares of the company's stock after selling 14,288 shares during the quarter. Truist Financial Corp owned approximately 0.09% of Azenta worth $2,101,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Farther Finance Advisors LLC boosted its stake in Azenta by 20.0% during the third quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company's stock valued at $74,000 after buying an additional 256 shares during the last quarter. KBC Group NV boosted its stake in Azenta by 48.5% during the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after buying an additional 698 shares during the period. Assenagon Asset Management S.A. bought a new position in Azenta during the fourth quarter valued at $200,000. Aigen Investment Management LP purchased a new stake in shares of Azenta in the third quarter valued at $214,000. Finally, Empowered Funds LLC bought a new stake in shares of Azenta in the 4th quarter worth about $293,000. Hedge funds and other institutional investors own 99.08% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on AZTA shares. TD Cowen upgraded shares of Azenta to a "hold" rating in a report on Thursday. Needham & Company LLC upped their target price on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research note on Thursday, February 6th. Evercore ISI raised their price target on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research note on Thursday, February 6th. Finally, Stephens restated an "overweight" rating and set a $60.00 price objective on shares of Azenta in a report on Thursday, January 2nd. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $58.75.

Azenta Price Performance

AZTA stock traded up $0.68 during mid-day trading on Friday, reaching $43.62. The company had a trading volume of 603,892 shares, compared to its average volume of 512,377. The company has a market capitalization of $1.99 billion, a PE ratio of -14.64 and a beta of 1.47. The firm has a 50 day moving average of $50.17 and a 200 day moving average of $47.71. Azenta, Inc. has a 12 month low of $38.82 and a 12 month high of $67.77.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.